Levoxyl (levothyroxine sodium tablets recall — Class II (D-0575-2025) · pharmaranks
Class IIOngoing
Levoxyl (levothyroxine sodium tablets recall
FDA recall D-0575-2025 · initiated Jul 29, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Subpotent drug
Details
Product
Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
This recall is linked to a product we cover: Levoxyl →
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.